Could a worm enzyme soothe diabetic nerve damage?

NCT ID NCT07475065

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether an oral supplement called DLBS1033 (made from earthworm proteins) can reduce nerve damage symptoms in adults with diabetic polyneuropathy. Thirty-four people with type 2 diabetes will receive either the supplement or a placebo for 28 days, alongside standard care. Researchers will measure changes in neuropathy severity, inflammation, and nerve growth factors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
DLBS1033 (lumbrokinase)
What this could lead to
If it works, this could point toward a new add-on treatment to ease nerve pain and improve nerve health in people with diabetic polyneuropathy.
What could go wrong
This is a small, early-phase trial with only 34 participants and a short 28-day treatment period. Results may not apply to everyone, and the supplement may not prove effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr. Moewardi Regional General Hospital

    Surakarta, Central Java, 57143, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.